Monday, April 06, 2020 7:17:28 PM
Say that out loud to yourselves.
87.4 million shares with an average price of +/- $5 = $437,000,000.
I would think it's safe to say that the institutions had plenty of support to liquidate their entire holdings.
People are trading this stock almost as if it went bankrupt.
A $17 IPO for $4.45/share is what we are left with. The tangible assets alone value US north of $10 a share easy. These insiders are forced to liquidate so these funds can get paid.
Just let it happen.
I for one am not selling at a loss. I rarely do. LK will the extremely volatile for the time being but will ultimately reverse course and head back up because it's just completely oversold.
Recent LKNCY News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/28/2024 11:24:18 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 11:34:36 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/23/2024 12:00:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 04:40:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/16/2023 11:30:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/13/2023 11:35:51 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/10/2023 02:28:13 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/03/2023 09:09:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/01/2023 11:00:04 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/07/2023 02:31:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/05/2023 11:35:22 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/03/2023 11:09:52 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/03/2023 11:03:46 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/01/2023 11:00:26 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM